Home/Filings/4/0001209191-21-051446
4//SEC Filing

Schlesinger Michael A. 4

Accession 0001209191-21-051446

CIK 0001828443other

Filed

Aug 12, 8:00 PM ET

Accepted

Aug 13, 5:22 PM ET

Size

20.4 KB

Accession

0001209191-21-051446

Insider Transaction Report

Form 4
Period: 2021-08-11
Schlesinger Michael A.
EVP, GC and Secretary
Transactions
  • Sale

    Ordinary Shares, $0.00001 par value

    2021-08-11$19.76/sh72,585$1,434,62187,637 total
  • Exercise/Conversion

    Ordinary Shares, $0.00001 par value

    2021-08-12$6.28/sh+8,100$50,86895,737 total
  • Sale

    Ordinary Shares, $0.00001 par value

    2021-08-12$20.00/sh8,100$162,00387,637 total
  • Exercise/Conversion

    Ordinary Shares, $0.00001 par value

    2021-08-13$6.28/sh+4,300$27,00491,937 total
  • Exercise/Conversion

    Ordinary Shares, $0.00001 par value

    2021-08-11$6.28/sh+72,585$455,834160,222 total
  • Sale

    Ordinary Shares, $0.00001 par value

    2021-08-13$20.00/sh4,300$86,00387,637 total
  • Exercise/Conversion

    Stock Option

    2021-08-1172,585350,922 total
    Exercise: $6.28Exp: 2024-10-22Ordinary Shares, $0.00001 par value (72,585 underlying)
  • Exercise/Conversion

    Stock Option

    2021-08-128,100342,822 total
    Exercise: $6.28Exp: 2024-10-22Ordinary Shares, $0.00001 par value (8,100 underlying)
  • Exercise/Conversion

    Stock Option

    2021-08-134,300338,522 total
    Exercise: $6.28Exp: 2024-10-22Ordinary Shares, $0.00001 par value (4,300 underlying)
Footnotes (6)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  • [F2]The Reporting Person undertakes to provide, upon request by the Securities Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported in this Form 4.
  • [F3]Represents the weighted average sales price for the price increments ranging from $19.4800 to $20.0700.
  • [F4]Represents the weighted average sales price for the price increments ranging from $20.0000 to $20.0050.
  • [F5]Represents the weighted average sales price for the price increments ranging from $20.0000 to $20.0100.
  • [F6]The stock option is fully vested and exercisable.

Issuer

Ortho Clinical Diagnostics Holdings plc

CIK 0001828443

Entity typeother

Related Parties

1
  • filerCIK 0001839441

Filing Metadata

Form type
4
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 5:22 PM ET
Size
20.4 KB